FIELD: medicine.
SUBSTANCE: method involves opening pyo-inflammatory focus. Rexod is introduced in addition to basic therapy. Rexod is introduced during the operation or immediately after the operation and then every day once a day intravenously in bolus dose. The drug is introduced during 4-5 days in physiologic saline or in 5% glucose solution at a dose of 0.2 mcg/kg of patient body weight.
EFFECT: enhanced effectiveness of treatment; improved general health state within a short period; reduced oxidation stress; prevented secondary active oxygen forms production.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR COMPLEX THERAPY OF AVERAGE-DEGREE ORAL PHLEGMONS | 2007 |
|
RU2320329C1 |
| METHOD OF MAXILLOFACIAL PHLEGMONS TREATMENT | 2007 |
|
RU2328292C1 |
| METHOD FOR TREATING ABSCESSES, SOFT TISSUE PHLEGMONS | 2006 |
|
RU2284825C1 |
| METHOD FOR TREATING ODONTOGENIC PHLEGMONS OF ORAL AREA | 2003 |
|
RU2244518C2 |
| METHOD FOR TREATING MAXILLOFACIAL ODONTOGENOUS PHLEGMON CASES IN AGED PATIENTS | 2004 |
|
RU2271210C2 |
| METHOD FOR TREATING ODONTOGENOUS FACE AND NECK PHLEGMON CASES | 2005 |
|
RU2307597C2 |
| METHOD OF TREATMENT OF PYO-INFLAMMATORY DISEASES OF MAXILLOFACIAL REGION | 1998 |
|
RU2141801C1 |
| METHOD FOR TREATING BIOLOGICAL TISSUES IN INFECTION FOCUS IN TREATING THE CASES OF ODONTOGENIC PHLEGMONS OF MAXILLOFACIAL AREA | 2000 |
|
RU2175258C1 |
| METHOD OF TREATING NON-SPECIFIC ODONTOGENIC DISEASES OF MAXILLOFACIAL REGION | 2009 |
|
RU2397763C1 |
| METHOD OF TREATMENT OF ODONTOGENOUS PHLEGMONS OF MAXILLOFACIAL REGION | 1996 |
|
RU2140769C1 |
